Literature DB >> 2392442

Determination of carcinogenic arylamine N-oxidation phenotype in humans by analysis of caffeine urinary metabolites.

F F Kadlubar1, G Talaska, M A Butler, C H Teitel, J P Massengill, N P Lang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2392442

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  5 in total

1.  Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct.

Authors:  G Talaska; A Z al-Juburi; F F Kadlubar
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

2.  A population and family study of CYP1A2 using caffeine urinary metabolites.

Authors:  A Catteau; Y C Bechtel; N Poisson; P R Bechtel; C Bonaïti-Pellie
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 3.  Clinically significant pharmacokinetic interactions between dietary caffeine and medications.

Authors:  J A Carrillo; J Benitez
Journal:  Clin Pharmacokinet       Date:  2000-08       Impact factor: 6.447

4.  Caffeine as a metabolic probe: a comparison of the metabolic ratios used to assess CYP1A2 activity.

Authors:  L J Notarianni; S E Oliver; P Dobrocky; P N Bennett; B W Silverman
Journal:  Br J Clin Pharmacol       Date:  1995-01       Impact factor: 4.335

5.  Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis.

Authors:  F F Kadlubar; M A Butler; K R Kaderlik; H C Chou; N P Lang
Journal:  Environ Health Perspect       Date:  1992-11       Impact factor: 9.031
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.